MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease

The aim of the study was to assess MMP-2 (matrix metalloproteinase-2) and TIMP-2 (tissue inhibitor of metalloproteinase-2) serum levels in patients with diverse types of heart failure (HF) and chronic kidney disease (CKD). 101 patients with chronic HF were enrolled. Each patient has assessed the ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobusiak-Prokopowicz, Malgorzata, Krzysztofik, Justyna, Kaaz, Konrad, Jolda-Mydlowska, Beata, Mysiak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter Open 2018
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004519/
https://www.ncbi.nlm.nih.gov/pubmed/29915813
http://dx.doi.org/10.1515/med-2018-0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004519/
https://www.ncbi.nlm.nih.gov/pubmed/29915813
http://dx.doi.org/10.1515/med-2018-0037

Ejemplares similares